Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor κB (NF-κB) signalling pathway
Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor κB (NF-κB) signalling pathway
复制标题
DOI:
10.1042/bj20101780
复制
发表时间:
2011-06-01
影响因子:
4.1
通讯作者:
Li, Yu-Xin
中科院分区:
文献类型:
--
作者:
Song, Zhen-Bo;Bao, Yong-Li;Li, Yu-Xin
TSP50 (testes-specific protease 50) is a testis-specific expression protein, which is expressed abnormally at high levels in breast cancer tissues. This makes it an attractive molecular marker and a potential target for diagnosis and therapy; however, the biological function of TSP50 is still unclear. In the present study, we show that overexpression of TSP50 in CHO (Chinese-hamster ovary) cells markedly increased cell proliferation and colony formation. Mechanistic studies have revealed that TSP50 can enhance the level of TNE alpha (tumour necrosis factor alpha)- and PMA-induced NF-kappa B (nuclear factor kappa B)-responsive reporter activity, I kappa B (inhibitor of NF-kappa B) alpha degradation and p65 nuclear translocation. In addition, the knockdown of endogenous TSP50 in MDA-MB-231 cells greatly inhibited NF-kappa B activity. Co-immunoprecipitation studies demonstrated an interaction of TSP50 with the NF-kappa B-I kappa B alpha complex, but not with the IKK (I kappa B kinase) alpha/beta-IKK gamma complex, which suggested that TSP50, as a novel type of protease, promoted the degradation of I kappa B alpha proteins by binding to the NE-kappa B-I kappa B alpha complex. Our results also revealed that TSP50 can enhance the expression of NE-kappa B target genes involved in cell proliferation. Furthermore, overexpression of a dominant-negative I kappa B mutant that is resistant to proteasome-mediated degradation significantly reversed TSP50-induced cell proliferation, colony formation and tumour formation in nude mice. Taken together, the results of the present study suggest that TSP50 promotes cell proliferation, at least partially, through activation of the NF-kappa B signalling pathway.